OZEM vs. ULTY ETF Comparison

Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to YieldMax Ultra Option Income Strategy ETF (ULTY)

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$27.32

Average Daily Volume

31,803

Number of Holdings ^*

* may have additional holdings in another (foreign) market

ULTY

YieldMax Ultra Option Income Strategy ETF

ULTY Description

The fund is an actively managed exchange-traded fund that seeks current income while providing direct and/or indirect exposure to the share price of select U.S. listed securities, subject to a limit on potential investment gains. It uses both traditional and synthetic covered call strategies that are designed to produce higher income levels when the underlying securities experience more volatility. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$9.98

Average Daily Volume

797,532

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	OZEM	ULTY
30 Days	-0.27%	5.18%
60 Days	-5.30%	4.99%
90 Days	3.02%	13.65%
12 Months

1 Overlapping Holdings

	Symbol	Grade	Weight in OZEM	Weight in ULTY	Overlap
	VKTX	A	3.69%	3.22%	3.22%

OZEM Overweight 13 Positions Relative to ULTY

Symbol	Grade	Weight
NVO	F	17.47%
LLY	F	15.52%
AZN	F	4.28%
ALT	D	3.69%
AMGN	C	3.25%
PFE	D	3.15%
SRRK	B	2.62%
REGN	F	2.61%
TERN	D	2.14%
TAK	C	1.96%
RYTM	D	1.7%
CORT	B	1.43%
OPK	C	1.35%

OZEM Underweight 17 Positions Relative to ULTY

Symbol	Grade	Weight
MSTR	B	-10.88%
NVDA	B	-5.68%
TQQQ	B	-5.56%
TNA	C	-5.4%
COIN	C	-5.25%
MARA	D	-4.81%
SAVA	D	-4.58%
TSLA	A	-4.55%
SGBX	F	-4.47%
U	C	-4.41%
RDFN	C	-4.19%
SMR	B	-4.19%
NVAX	F	-3.88%
AMSC	A	-3.49%
ENPH	F	-3.04%
SATS	B	-3.04%
UPST	B	-2.89%

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic